Network biology methods for drug repositioning

Post-genomic Approaches in Drug and Vaccine Development

Volumn , Issue , 2015, Pages 115-131

  Zhu, Cheng ^a   Wu, Chao ^b   Jegga, Anil G ^a  

^a University of Cincinnati   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84991887553     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (60)

1. Li, Y.Y. and S.J. Jones, Drug repositioning for personalized medicine. Genome Med, 2012. 4(3): p. 27.
2. Boguski, M.S., K.D. Mandl, and V.P. Sukhatme, Drug discovery. Repurposing with a difference. Science, 2009. 324(5933): p. 1394-5.
3. Sardana, D., et al., Drug repositioning for orphan diseases. Brief Bioinform, 2011. 12(4): p. 346-56.
4. Pujol, A., et al., Unveiling the role of network and systems biology in drug discovery. Trends Pharmacol Sci, 2010. 31(3): p. 115-23.
5. Wishart, D.S., Discovering drug targets through the web. Comp Biochem Physiol Part D Genomics Proteomics, 2007. 2(1): p. 9-17.
6. Keiser, M.J., et al., Predicting new molecular targets for known drugs. Nature, 2009. 462(7270): p. 175-81.
7. Kinnings, S.L., et al., Drug discovery using chemical systems biol-ogy: repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis. PLoS Comput Biol, 2009. 5(7): p. e1000423.
8. Campillos, M., et al., Drug target identification using side-effect similar-ity. Science, 2008. 321(5886): p. 263-6.
9. Yang, L. and P. Agarwal, Systematic drug repositioning based on clinical side-effects. PLoS One, 2011. 6(12): p. e28025.
10. Lamb, J., The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer, 2007. 7(1): p. 54-60.
11. Lamb, J., et al., The Connectivity Map: using gene-expression signa-tures to connect small molecules, genes, and disease. Science, 2006. 313(5795): p. 1929-35.
12. Agarwal, P. and D.B. Searls, Literature mining in support of drug discovery. Brief Bioinform, 2008. 9(6): p. 479-92.
13. Freeman, L., A set of measures of centrality based upon betweenness. Sociometry, 1977. 40: p. 35-41.
14. Beauchamp, M.A., An improved index of centrality. Behav. Sci., 1965(10): p. 161-163.
15. Sabidussi, G., The centrality index of a graph. Psychometrika, 1966. 31: p. 581-603.
16. Brin, S. and L. Page, The anatomy of a large-scale hypertextual Web search engine. Computer Networks and ISDN Systems, 1998(30): p. 107-117.
17. Watts, D.J., and S. H. Strogatz, Collective dynamics of 'small-world' networks. Nature, 1998(393): p. 440-442.
18. Friedkin, N.E., Structural cohesion and equivalence explanations of social homogeneity. Sociol. Method. Res., 1984. 12: p. 235-261.
19. Palla, G., et al., Uncovering the overlapping community structure of complex networks in nature and society. Nature, 2005. 435(7043): p. 814-8.
20. Hartwell, L.H., et al., From molecular to modular cell biology. Nature, 1999. 402(6761 Suppl): p. C47-52.
21. Eisenberg, D., et al., Protein function in the post-genomic era. Nature, 2000. 405(6788): p. 823-6.
22. Girvan, M. and M.E. Newman, Community structure in social and biological networks. Proc Natl Acad Sci U S A, 2002. 99(12): p. 7821-6.
23. Guimera, R. and L.A. Nunes Amaral, Functional cartography of complex metabolic networks. Nature, 2005. 433(7028): p. 895-900.
24. Rives, A.W. and T. Galitski, Modular organization of cellular networks. Proc Natl Acad Sci U S A, 2003. 100(3): p. 1128-33.
25. Székely, G.J.a.R., M. L., Hierarchical clustering via Joint Between-Within Distances: Extending Ward's Minimum Variance Method. Journal of Classification, 2005. 22: p. 151-183.
26. Samanta, M.P. and S. Liang, Predicting protein functions from redun-dancies in large-scale protein interaction networks. Proc Natl Acad Sci U S A, 2003. 100(22): p. 12579-83.
27. Xenarios, I., et al., DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions. Nucleic Acids Res, 2002. 30(1): p. 303-5.
28. Kanungo, T.M., D. M.; Netanyahu, N. S.; Piatko, C. D.; Silverman, R.; Wu, A. Y., An efficient k-means clustering algorithm: Analysis and implementation. EEE Trans. Pattern Analysis and Machine Intelligence, 2002. 24: p. 881-892.
29. Hans-Peter Kriegel, P.K., Jörg Sander, Arthur Zimek Density-based Clustering. WIREs Data Mining and Knowledge Discovery, 2011. 1(3): p. 231-240.
30. Martin Ester, H.-P.K., Jörg Sander, Xiaowei Xu A density-based algo-rithm for discovering clusters in large spatial databases with noise, in Proceedings of the Second International Conference on Knowledge Discovery and Data Mining (KDD-96). 1996. p. 226-231.
31. Yu, H., et al., The importance of bottlenecks in protein networks: cor-relation with gene essentiality and expression dynamics. PLoS Comput Biol, 2007. 3(4): p. e59.
32. Vincent D Blondel, J.-L.G., Renaud Lambiotte, Etienne Lefebvre, Fast unfolding of communities in large networks. Journal of Statistical Mechanics: Theory and Experiment, 2008. 10.
33. Junker, B.H., D. Koschutzki, and F. Schreiber, Exploration of biological network centralities with CentiBiN. BMC Bioinformatics, 2006. 7: p. 219.
34. Chandra, N. and J. Padiadpu, Network approaches to drug discovery. Expert Opin Drug Discov, 2013. 8(1): p. 7-20.
35. Wu, Z., Y. Wang, and L. Chen, Network-based drug repositioning. Mol Biosyst, 2013. 9(6): p. 1268-81.
36. Barabasi, A.L. and Z.N. Oltvai, Network biology: understanding the cell's functional organization. Nat Rev Genet, 2004. 5(2): p. 101-13.
37. Li, Y. and P. Agarwal, A pathway-based view of human diseases and disease relationships. PLoS One, 2009. 4(2): p. e4346.
38. Mei, H., et al., Opportunities in systems biology to discover mechanisms and repurpose drugs for CNS diseases. Drug Discov Today, 2012. 17(21-22): p. 1208-16.
39. Hu, G. and P. Agarwal, Human disease-drug network based on genomic expression profiles. PLoS One, 2009. 4(8): p. e6536.
40. Wu, M., X. Yang, and C. Chan, A dynamic analysis of IRS-PKR signaling in liver cells: a discrete modeling approach. PLoS One, 2009. 4(12): p. e8040.
41. Jeong, H., et al., Lethality and centrality in protein networks. Nature, 2001. 411(6833): p. 41-2.
42. Florez, A.F., et al., Protein network prediction and topological anal-ysis in Leishmania major as a tool for drug target selection. BMC Bioinformatics, 2010. 11: p. 484.
43. Raman, K., K. Yeturu, and N. Chandra, targetTB: a target identifica-tion pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis. BMC Syst Biol, 2008. 2: p. 109.
44. Yang, L., et al., Identifying unexpected therapeutic targets via chemical-protein interactome. PLoS One, 2010. 5(3): p. e9568.
45. Zhao, S. and S. Li, Network-based relating pharmacological and genomic spaces for drug target identification. PLoS One, 2010. 5(7): p. e11764.
46. Wishart, D.S., et al., DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res, 2008. 36(Database issue): p. D901-6.
47. Lee, H.S., et al., Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drug. BMC Syst Biol, 2012. 6: p. 80.
48. Li, S., et al., Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae. BMC Bioinformatics, 2010. 11 Suppl 11: p. S6.
49. Iorio, F., et al., Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc Natl Acad Sci U S A, 2010. 107(33): p. 14621-6.
50. Suthram, S., et al., Network-based elucidation of human disease similar-ities reveals common functional modules enriched for pluripotent drug targets. PLoS Comput Biol, 2010. 6(2): p. e1000662.
51. Barrett, T., et al., NCBI GEO: mining tens of millions of expres-sion profiles-database and tools update. Nucleic Acids Res, 2007. 35(Database issue): p. D760-5.
52. Goel, R., et al., Human Protein Reference Database and Human Protein-pedia as resources for phosphoproteome analysis. Mol Biosyst, 2012. 8(2): p. 453-63.
53. Chiang, A.P. and A.J. Butte, Systematic evaluation of drug-disease relationships to identify leads for novel drug uses. Clin Pharmacol Ther, 2009. 86(5): p. 507-10.
54. Vincent, D.B., et al., Fast unfolding of communities in large net-works. Journal of Statistical Mechanics: Theory and Experiment, 2008. 2008(10): p. P10008.
55. Nepusz, T., H. Yu, and A. Paccanaro, Detecting overlapping protein complexes in protein-protein interaction networks. Nat Meth, 2012. 9(5): p. 471-472.
56. Kanehisa, M., et al., KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Research, 2010. 38(suppl 1): p. D355-D360.
57. Chen, J., et al., ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Research, 2009. 37 (suppl 2): p. W305-W311.
58. Sekulic, A., et al., Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med, 2012. 366(23): p. 2171-9.
59. Von Hoff, D.D., et al., Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med, 2009. 361(12): p. 1164-72.
60. Tang, J.Y., et al., Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N Engl J Med, 2012. 366(23): p. 2180-8.